As of 2024-07-27, the Intrinsic Value of Helix Biopharma Corp (HBP.TO) is -0.13 CAD. This HBP.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.27 CAD, the upside of Helix Biopharma Corp is -149.10%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-0.13 - -0.13	-0.13	-149.10%
P/E	(0.00) - (0.01)	(0.00)	-100.9%
DDM - Stable	(0.19) - (0.51)	(0.35)	-229.1%
DDM - Multi	(0.17) - (0.38)	(0.24)	-188.7%